Newsletter - August 2011

PDF
Print
E-mail
Written by Shobhit
Tuesday, 23 August 2011 09:47

Dolcera

August 2011
 

   Reports                     Blogs                     Events                                             Blog   Youtube   Twitter   LinkedIn

   

Dolcera Report: Interferon for the treatment of Melanoma

 

Melanoma is a serious type of skin cancer. It begins in cells called melanocytes that make melanin, which gives skin its color. If the skin receives too much UV light, the melanocytes may begin to grow abnormally and become cancerous.

 

A beacon of hope in the treatment of melanoma has been attack by the host’s immune system. This has resulted in the testing of a remarkably broad spectrum of immunotherapies, many of which failed to demonstrate clinical impact. One exception is, however, the use of adjuvant interferon (IFN) alpha.

 

There are multiple antitumor effects of IFN-{alpha}. These include a direct antiproliferative effect, increase of natural killer cell activity, and the upregulation of tumor antigens and/or HLA class I and class II antigens. Initial phase II clinical studies in metastatic melanoma showed response rates of 10%–20%.

 

Dolcera's research focuses on a prior art search on usage of interferon for the treatment of melanoma. The research consists of patents in US, EP, PCT, JP, Great Britain, and German patent records. Performed MPI-INPADOC search which cover bibliographic data for 71 countries and legal status for 42 countries
 

 

 

     

Check out the findings in detail

  Dashboard

  Interactive Taxonomy

  Concept Table

  Intellectual Property

  Sample Analysis

      and Patent Ranking

  IP Activity Graphs Of

       Sample Patents

  Market Reports

  Biosimilars of Interferons


What's new on Dolcera Blog

  Organ Printing - Need an organ? Print it

  The Wellness Chip takes clinical diagnosis to newer heights

  Impotent Warriors- War against Malaria


Events

  Global Patent Congress 2011, 21 September 2011, Copenhagen, Denmark

 ICIC Conference 2011, 23 - 26 October, Barcelona, Spain

  IPWARE Summit 2011, 5 - 7 October 2011 - Sanremo, Italy

   Contact us to know about upcoming Webinars or Call: +1-650-425-6772

 

In this issue

Dolcera Report

- Interferon for treatment of Melanoma

 

Dolcera Blog

- Organ Printing: Need an organ? Print it

 

- The Wellness Chip takes clinical diagnosis to newer heights

 

- Impotent Warriors: War against Malaria

 

Events

- Global Patent Congress 2011

- ICIC Conference 2011

- IPWARE Summit 2011

 

About Dolcera

Dear Readers,

Greetings from Dolcera!

We are back with our August 2011 newsletter.
 

Dolcera's IP and Market Research services help companies innovate and win in the marketplace. Working with dozens of Fortune 500 companies, as well as mid-sized and small enterprises, we have delivered a range of insights to companies in domains ranging from technology, medical devices and semiconductors to food and beverages, and consumer goods.
 

This newsletter is aimed at keeping you informed about some of the latest market and technology trends in the industry.
 

We look forward to your feedback.
 

Kind regards,
Dolcera Team

 

Our Services

Patent Research

    and Analytics

 

Business and

    Market Research

 

Knowledge Management

    and Collaboration tools

Dolcera Corporation
3555, South El Camino, Real#305
San Mateo, California
Phone: +1-650-425-6772
info@dolcera.com

Dolcera

    www.dolcera.com

Last Updated ( Tuesday, 04 October 2011 12:16 )